- ►onlinejacc.org SW Lee, SW Park, YH Kim, SC Yun, DW Park, … - Journal of the American College of Cardiology, 2008 - Elsevier The aim of this study was to compare the effectiveness of sirolimus-eluting
stents (SES) and paclitaxel-eluting stents (PES) in patients with diabetes
mellitus (DM). ... Drug-eluting stent implantation significantly improved ... Cited by 8 - Related articles - All 13 versions
C Tamburino, A La Manna, ME Di Salvo, G … - JACC: Cardiovascular Interventions, 2009 - Elsevier This study sought to assess safety and efficacy of implantation of the Catania
Coronary Stent System with Nanothin Polyzene-F (CeloNova BioSciences, Newnan,
Georgia) in human coronary arteries with clinical data and comprehensive ... Cited by 3 - Related articles - All 3 versions
O Fröbert, B Lagerqvist, J Carlsson, J … - Journal of the American College of Cardiology, 2009 - Elsevier Our aim was to evaluate restenosis rate of drug-eluting stents (DES) in patients
with and without diabetes mellitus (DM) in a real-world setting. ... DES seem
less effective in patients with DM. ... The SCAAR (Swedish Coronary ... Cited by 2 - Related articles - All 37 versions
M Maeng, LO Jensen, AM Galloe, P Thayssen, … - The American journal of cardiology, 2009 - Elsevier The aim of the present study was to evaluate angiographic late luminal loss
after the implantation of sirolimus-eluting Cypher stents and paclitaxel-eluting
Taxus stents in patients with diabetes. The study was a Danish multicenter, ... Cited by 1 - Related articles - All 32 versions
M Balducelli, P Ortolani, P Marzaroli, G … - Catheterization and Cardiovascular Interventions, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles
RA Byrne, A Kastrati - Catheterization and Cardiovascular Diagnosis - interscience.wiley.com Drug-eluting stent (DES) therapy reduces restenosis in patients with diabetes
when compared with bare metal stent implantation. There are significant
differences between commercially available DES platforms both in terms of ... Related articles - All 2 versions
C Cola, S Brugaletta, VM Yuste, B Campos, DJ … - Vascular Health and Risk Management, 2009 - pubmedcentral.nih.gov Coronary stent thrombosis is a serious problem in the drug-eluting stent era.
Despite aggressive antiplatelet therapy during and after percutaneous coronary
intervention (PCI), the incidence of sub-acute stent thrombosis remains ... Related articles - All 6 versions
G HELLIGE, S WINDECKER - Journal of Interventional Cardiology, 2009 - interscience.wiley.com Drug-eluting stents (DES) have been appraised as breakthrough technology owing
to their potent reduction of restenosis, an important nuisance in the quality of
life of affected patients, the rare cause of myocardial infarction, and the ... Related articles - All 2 versions
A Chieffo, I Milan - cordiscardiology.jp （BMS）留置によるPCIより、CABGの方が優れている
ことが示唆された(2-5)。これらの成績は、現在のガイド
ラインに反映され、再血行再建を必要とするほとんどの ... Related articles - View as HTML